Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma-Reference-Cited by-同舟云学术

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma

Published:2017-10-10 Issue:6 Volume:59 Page:1420-1426
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Cencini Emanuele¹,Puccini Benedetta²,Rigacci Luigi²,Fabbri Alberto¹,Kovalchuk Sofia²,Mannelli Lara²,Benelli Gemma²,Carfagno Tommaso³,Simontacchi Gabriele⁴,Bocchia Monica¹,Bosi Alberto²

Affiliation:

1. Unit of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy;

2. Hematology Department, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy;

3. Radiotherapy Department, Azienda Ospedaliera Universitaria Senese, Siena, Italy;

4. Radiotherapy Department, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1387909

Reference44 articles.

1. Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5)

2. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Non-Hodgkin lymphoma

4. Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pixantrone in patients with relapsed/refractory diffuse large B‐cell lymphoma: A real‐life, retrospective, multicenter trial on behalf of the “RTL” (Regional TUSCAN Lymphoma Network)—Authors' reply to Morris and colleagues;European Journal of Haematology;2022-07-28

2. Follicular lymphoma: the diminishing role of chemotherapy;Journal of Cancer Metastasis and Treatment;2022

3. Recent Development of Monoclonal Antibodies Targeting Tyrosine Kinase in ROS-Mediated Cancer;Handbook of Oxidative Stress in Cancer: Mechanistic Aspects;2022

4. Radiotherapy for early and advanced stages Follicular Lymphoma;Clinics;2021

5. Recent Development of Monoclonal Antibodies Targeting Tyrosine Kinase in ROS-Mediated Cancer;Handbook of Oxidative Stress in Cancer: Mechanistic Aspects;2021